Valneva

Valneva, a Pharmaceutical Preparation Manufacturing company headquartered in France, reported approximately 59,310,000 kg CO2e in total greenhouse gas emissions for 2024. This includes about 1,277,000 kg CO2e from Scope 1 emissions, 2,499,000 kg CO2e from Scope 2 emissions (location-based), and 55,534,000 kg CO2e from Scope 3 emissions.

Key Scope 3 categories for 2024 include approximately 34,964,000 kg CO2e from purchased goods and services, 9,044,000 kg CO2e from upstream transportation and distribution, and 5,791,000 kg CO2e from downstream transportation and distribution.

In 2023, Valneva's total emissions were about 4,751,000 kg CO2e, comprising approximately 1,688,000 kg CO2e from Scope 1, 1,477,000 kg CO2e from Scope 2, and 1,586,000 kg CO2e from Scope 3.

The company has set a near-term target to reduce its Scope 1 and Scope 2 CO2 emissions from laboratories and manufacturing sites by 50% from a 2022 baseline by 2030. Between 2019 and 2023, Valneva achieved a 48% reduction in its own CO2 emissions from gas and electricity consumed, representing a decrease of 1,630 tonnes of CO2 emissions, primarily due to the shift to green electricity.